Literature DB >> 29909138

Narcolepsy and Hypothalamic Region Tumors: Presentation and Evolution.

Alexander G Weil1, Katherine Muir2, Juliette Hukin3, Alex Desautels4, Véronique Martel5, Sébastien Perreault6.   

Abstract

OBJECTIVE: Because most cases of brain tumor-associated narcolepsy have been published in the form of case reports or small series, the clinical presentation and evolution have not been well described. We sought to better define the epidemiology, etiology, and outcome of brain tumor-related narcolepsy.
METHODS: We conducted an extensive review of the literature to identify cases of narcolepsy associated with brain tumors. Only cases of brain tumors involving the hypothalamic region including the suprasellar, sellar, and thalamus were included in this study.
RESULTS: We report a child with possible narcolepsy in a child with a brain tumor. Through our literature review, we identified 25 additional cases of narcolepsy associated with brain tumors affecting the hypothalamic area. Most symptomatic narcolepsy cases were reported in children (70%). Half of the patients (13 of 25, 52%) developed narcolepsy after surgery, whereas 11 patients (44%) were symptomatic at the time of the tumor diagnosis. Ten patients had narcolepsy without cataplexy. Most cases were associated with craniopharyngioma (38%), adenoma (24%), and glioma (14%). Three, including our patient, experienced a complete resolution of symptoms. All patients underwent biopsy and were treated with adjuvant therapy. For patients with persistent symptoms, most (60%) improved following medical management of narcolepsy.
CONCLUSION: This study represents the largest compilation of patients with this association. Our study allows us to better understand the etiology and outcome of patients with narcolepsy-related brain tumors.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain tumor; Craniopharyngioma; Hypothalamus; Narcolepsy

Mesh:

Year:  2018        PMID: 29909138     DOI: 10.1016/j.pediatrneurol.2017.12.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Excessive daytime sleepiness due to brain tumor.

Authors:  Raissa Aoun; Malvika Kaul; Ashima Sahni
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

Review 2.  Narcolepsy Presentation in Diverse Populations: an Update.

Authors:  Karen Spruyt
Journal:  Curr Sleep Med Rep       Date:  2020-11-25

Review 3.  Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update.

Authors:  Andrea Romigi; Tiziana Feola; Simone Cappellano; Michelangelo De Angelis; Giacomo Pio; Marco Caccamo; Federica Testa; Giuseppe Vitrani; Diego Centonze; Claudio Colonnese; Vincenzo Esposito; Marie-Lise Jaffrain-Rea
Journal:  Front Neurol       Date:  2022-02-09       Impact factor: 4.003

Review 4.  Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management.

Authors:  Irtiza N Sheikh; Michael Roth; Peter L Stavinoha
Journal:  Children (Basel)       Date:  2021-11-29

5.  Sleep disturbances in craniopharyngioma: a challenging diagnosis.

Authors:  Ramona Cordani; Marco Veneruso; Flavia Napoli; Claudia Milanaccio; Antonio Verrico; Alessandro Consales; Matteo Cataldi; Daniela Fava; Natascia Di Iorgi; Mohamad Maghnie; Maria Margherita Mancardi; Lino Nobili
Journal:  J Neurol       Date:  2021-09-14       Impact factor: 4.849

6.  Increased Serum Prolactin and Excessive Daytime Sleepiness: An Attempt of Proof-of-Concept Study.

Authors:  Maria P Mogavero; Filomena I I Cosentino; Bartolo Lanuzza; Mariangela Tripodi; Giuseppe Lanza; Debora Aricò; Lourdes M DelRosso; Fabio Pizza; Giuseppe Plazzi; Raffaele Ferri
Journal:  Brain Sci       Date:  2021-11-28

7.  Onset of narcolepsy type 1 in a paraneoplastic encephalitis associated with a thymic seminoma.

Authors:  Simone Rossi; Gian Maria Asioli; Giovanni Rizzo; Giombattista Sallemi; Monica Moresco; Christian Franceschini; Fabio Pizza; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.